Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-03

FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for cetirizine hydrochloride from Padagis Israel Pharmaceuticals Ltd. It is a generic antihistamine indicated for allerg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

SUPPL AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)